China Reform Health Management and Services Group Co Ltd
Launch date
Employees
Market cap
$941m
Enterprise valuation
$799m (Public information from Sep 2024)
Share price
CNY7.65 000503.SZ
Beijing China (HQ)
Financials
Estimates*
| CNY | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
| Revenues | - | - | 130m | 207m | 253m | 311m | 330m |
| % growth | - | - | - | 60 % | 22 % | 23 % | 6 % |
| EBITDA | - | - | 73.6m | (111m) | (112m) | (65.7m) | (55.7m) |
| % EBITDA margin | - | - | 57 % | (53 %) | (44 %) | (21 %) | (17 %) |
| Profit | - | - | 17.4m | (243m) | (176m) | (84.5m) | (79.8m) |
| % profit margin | - | - | 13 % | (117 %) | (70 %) | (27 %) | (24 %) |
| EV / revenue | - | - | 112.1x | 31.9x | 57.9x | 27.9x | 35.7x |
| EV / EBITDA | - | - | 197.9x | -59.7x | -130.6x | -132.1x | -211.8x |
| R&D budget | - | - | 5.8m | 16.4m | 16.3m | 9.6m | <1m |
| R&D % of revenue | - | - | 4 % | 8 % | 6 % | 3 % | - |
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | N/A | IPO | |
| Total Funding | - | ||
